Selective Peroxisome Proliferator-Activated Receptor-γ Modulation in the Treatment of Hypertension and Metabolic Syndrome: The Role of Angiotensin II Receptor Blockers

By Borghi Claudio  

High Blood Pressure & Cardiovascular Prevention, Vol. 13, Iss. 3, 2006-01 ,pp. : 81-84

Adis International

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptor- in macrophage lipid homeostasis

By Lee C.-H.   Evans R.M.  

Trends in Endocrinology and Metabolism, Vol. 13, Iss. 8, 2002-10 ,pp. : 331-335

Elsevier

Access to resources Recommend Favorite

Effect of a novel non-thiazolidinedione peroxisome proliferator-activated receptor α/γ agonist on glucose uptake

By Hu X.   Feng Y.   Liu X.   Zhao X.-F.   Yu J.-H.   Yang Y.-S.   Sydow-Bäckman M.   Hörling J.   Zierath J.   Leng Y.  

Diabetologia, Vol. 50, Iss. 5, 2007-05 ,pp. : 1048-1057

Springer Publishing Company

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor β/δ Activation Improves Angiotensin II-Induced Cardiac Hypertrophy in Vitro

By Sheng Li   Ye Ping   Liu Yong-xue   Han Chun-guang   Zhang Zhi-yi  

Clinical and Experimental Hypertension, Vol. 30, Iss. 2, 2008-02 ,pp. : 109-119

Informa Healthcare

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor γ as a Novel Therapeutic Target in Asthma

By Park Seoung Ju   Lee Yong Chul  

Journal of Asthma, Vol. 45, Iss. 1, 2008-01 ,pp. : 1-8

Informa Healthcare

Access to resources Recommend Favorite